BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 17368478)

  • 21. Thermodynamics of mRNA 5' cap binding by eukaryotic translation initiation factor eIF4E.
    Niedzwiecka A; Darzynkiewicz E; Stolarski R
    Biochemistry; 2004 Oct; 43(42):13305-17. PubMed ID: 15491137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biophysical approach to studies of cap-eIF4E interaction by synthetic cap analogs.
    Niedzwiecka A; Stepinski J; Antosiewicz JM; Darzynkiewicz E; Stolarski R
    Methods Enzymol; 2007; 430():209-45. PubMed ID: 17913640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Candidate tumor suppressor DDX3 RNA helicase specifically represses cap-dependent translation by acting as an eIF4E inhibitory protein.
    Shih JW; Tsai TY; Chao CH; Wu Lee YH
    Oncogene; 2008 Jan; 27(5):700-14. PubMed ID: 17667941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Binding analyses for the interaction between plant virus genome-linked protein (VPg) and plant translational initiation factors.
    Miyoshi H; Suehiro N; Tomoo K; Muto S; Takahashi T; Tsukamoto T; Ohmori T; Natsuaki T
    Biochimie; 2006; 88(3-4):329-40. PubMed ID: 16300873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural basis of m7GpppG binding to the nuclear cap-binding protein complex.
    Calero G; Wilson KF; Ly T; Rios-Steiner JL; Clardy JC; Cerione RA
    Nat Struct Biol; 2002 Dec; 9(12):912-7. PubMed ID: 12434151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative analysis of influenza virus RNP interaction with RNA cap structures and comparison to human cap binding protein eIF4E.
    Hooker L; Sully R; Handa B; Ono N; Koyano H; Klumpp K
    Biochemistry; 2003 May; 42(20):6234-40. PubMed ID: 12755627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cap-binding activity of an eIF4E homolog from Leishmania.
    Yoffe Y; Zuberek J; Lewdorowicz M; Zeira Z; Keasar C; Orr-Dahan I; Jankowska-Anyszka M; Stepinski J; Darzynkiewicz E; Shapira M
    RNA; 2004 Nov; 10(11):1764-75. PubMed ID: 15388875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cap and cap-binding proteins in the control of gene expression.
    Topisirovic I; Svitkin YV; Sonenberg N; Shatkin AJ
    Wiley Interdiscip Rev RNA; 2011; 2(2):277-98. PubMed ID: 21957010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural scaffold for eIF4E binding selectivity of 4E-BP isoforms: crystal structure of eIF4E binding region of 4E-BP2 and its comparison with that of 4E-BP1.
    Fukuyo A; In Y; Ishida T; Tomoo K
    J Pept Sci; 2011 Sep; 17(9):650-7. PubMed ID: 21661078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eukaryotic translation initiation: there are (at least) two sides to every story.
    Sachs AB; Varani G
    Nat Struct Biol; 2000 May; 7(5):356-61. PubMed ID: 10802729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The potyviral virus genome-linked protein VPg forms a ternary complex with the eukaryotic initiation factors eIF4E and eIF4G and reduces eIF4E affinity for a mRNA cap analogue.
    Michon T; Estevez Y; Walter J; German-Retana S; Le Gall O
    FEBS J; 2006 Mar; 273(6):1312-22. PubMed ID: 16519694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative proteomics identifies Gemin5, a scaffolding protein involved in ribonucleoprotein assembly, as a novel partner for eukaryotic initiation factor 4E.
    Fierro-Monti I; Mohammed S; Matthiesen R; Santoro R; Burns JS; Williams DJ; Proud CG; Kassem M; Jensen ON; Roepstorff P
    J Proteome Res; 2006 Jun; 5(6):1367-78. PubMed ID: 16739988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Eukaryotic initiation factor 4E variants alter the morphology, proliferation, and colony-formation properties of MDA-MB-435 cancer cells.
    Goldson TM; Vielhauer G; Staub E; Miller S; Shim H; Hagedorn CH
    Mol Carcinog; 2007 Jan; 46(1):71-84. PubMed ID: 17091471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. After fertilization of sea urchin eggs, eIF4G is post-translationally modified and associated with the cap-binding protein eIF4E.
    Oulhen N; Salaün P; Cosson B; Cormier P; Morales J
    J Cell Sci; 2007 Feb; 120(Pt 3):425-34. PubMed ID: 17213333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of human eIF4E by 4E-BP1: binding analysis using surface plasmon resonance.
    Youtani T; Tomoo K; Ishida T; Miyoshi H; Miura K
    IUBMB Life; 2000 Jan; 49(1):27-31. PubMed ID: 10772338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Five eIF4E isoforms from Arabidopsis thaliana are characterized by distinct features of cap analogs binding.
    Kropiwnicka A; Kuchta K; Lukaszewicz M; Kowalska J; Jemielity J; Ginalski K; Darzynkiewicz E; Zuberek J
    Biochem Biophys Res Commun; 2015 Jan; 456(1):47-52. PubMed ID: 25446076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of N-terminal region of eIF4E and Ser65-phosphorylation of 4E-BP1 on interaction between eIF4E and 4E-BP1 fragment peptide.
    Tomoo K; Abiko F; Miyagawa H; Kitamura K; Ishida T
    J Biochem; 2006 Aug; 140(2):237-46. PubMed ID: 16825247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification and function of the second eIF4E-binding region in N-terminal domain of eIF4G: comparison with eIF4E-binding protein.
    Umenaga Y; Paku KS; In Y; Ishida T; Tomoo K
    Biochem Biophys Res Commun; 2011 Oct; 414(3):462-7. PubMed ID: 21964297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of eukaryotic mRNA stability via the cap-binding translation complex eIF4F.
    Ramirez CV; Vilela C; Berthelot K; McCarthy JE
    J Mol Biol; 2002 May; 318(4):951-62. PubMed ID: 12054793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Binding preference of eIF4E for 4E-binding protein isoform and function of eIF4E N-terminal flexible region for interaction, studied by SPR analysis.
    Abiko F; Tomoo K; Mizuno A; Morino S; Imataka H; Ishida T
    Biochem Biophys Res Commun; 2007 Apr; 355(3):667-72. PubMed ID: 17316564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.